Berkshire adds Delta and Macy’s stakes in first quarter By Investing.com

Berkshire Hathaway disclosed new first-quarter stakes in Delta Air Lines and Macy’s, buying nearly 40 million Delta shares and around 4 million Macy’s shares. The stock market response was positive after hours, with Delta up 3% and Macy’s up 5%, while exited holdings such as UnitedHealth fell 2.4% after the filing. The filing also confirms Berkshire continued to favor concentrated core positions under CEO Greg Abel.

Analysis

The immediate signal is not about Delta or Macy’s as standalone businesses; it is about capital being reallocated from mature financial/healthcare compounders into more cyclical, higher-beta cash-flow stories. That shift matters because it suggests the new stewardship is willing to tolerate more operating leverage in exchange for valuation upside, which can spill over into peer re-rating: airlines and department stores may see short-lived multiple support from being “validated” by a high-conviction owner, while payment networks and managed care lose some scarcity premium.

The second-order effect is on positioning. A Berkshire buy can create forced buying from momentum and event-driven funds, but the follow-through usually fades unless fundamentals confirm within 1-2 quarters. For DAL, the bullish read is less about passenger demand and more about capacity discipline and fuel-price sensitivity; for M, the key is whether improving traffic can offset margin pressure from promotions and inventory risk. If neither shows clean operating leverage by the next print, the post-filing enthusiasm likely mean-reverts.

The governance angle is more important than the portfolio changes themselves: Abel is signaling a less fragmented, more concentrated capital-allocation regime. That should reduce the probability of incremental niche acquisitions and increase the bar for small positions, which is negative for names that may have been under active review rather than conviction-owned. The exits in AON, AMZN, MA, V, and UNH also remove a subtle overhang for those stocks if the market had been attributing them to Berkshire’s longer-term view rather than a smaller, more tactical sleeve.

The contrarian view is that the market may be over-reading “new CEO, new style” into what is still a relatively small set of portfolio actions. Berkshire’s core equity identity remains unchanged, and the portfolio still leans heavily into financials, energy, and consumer staples; one quarter of allocation drift is not enough to declare a regime shift. The more durable trade is not chasing the headline beneficiaries, but monitoring whether Abel follows with additional cyclical adds or whether this was simply cleanup of legacy positions.

Key Decisions for Investors

• Trade DAL as a 1-3 month event-driven long only if it can hold post-news gains; upside is multiple expansion from sponsorship, but downside is rapid mean reversion if the next earnings guide implies softer pricing or higher CASM.
• Fade the pop in M with a tactical short or put spread over 4-8 weeks; the stock benefits from sentiment more than fundamentals, and any inventory/margin disappointment should compress the move quickly.
• Relative-value pair: long DAL / short UAL or AAL for 6-12 weeks, targeting a sympathy bid with better balance-sheet-backed durability; risk is weaker industry demand or fuel spikes that hit the whole group.
• Use weakness in UNH and MA as an opportunity to add only if multiples de-rate further on no-fundamental-news selling; the Berkshire exit may remove a technical support, but the long-term earnings power is largely unchanged, so the better entry is on indiscriminate post-filing pressure.
• Do not extrapolate into BRK.B as a “new era” trade; keep it as a steady compounding hold, with the real signal to watch being whether Abel makes another concentrated, publicly visible purchase within the next 1-2 quarters.